Toronto - Delayed Quote CAD

Healthcare Special Opportunities Fund (MDS-UN.TO)

Compare
13.00 0.00 (0.00%)
At close: December 27 at 9:30:00 AM EST
Loading Chart for MDS-UN.TO
DELL
  • Previous Close 13.00
  • Open 13.00
  • Bid 12.65 x --
  • Ask 13.00 x --
  • Day's Range 13.00 - 13.00
  • 52 Week Range 11.41 - 14.39
  • Volume 2,000
  • Avg. Volume 580
  • Market Cap (intraday) 20.401M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 6.88
  • EPS (TTM) 1.89
  • Earnings Date --
  • Forward Dividend & Yield 0.24 (2.14%)
  • Ex-Dividend Date Sep 28, 2023
  • 1y Target Est --

Healthcare Special Opportunities Fund is a closed-ended balanced mutual fund launched and managed by LDIC Inc. The fund invests into public equity and fixed income developed markets. It seeks to invest in stocks of companies that are operating in medical and healthcare sectors. The fund primarily invests in growth stocks of companies having mid and small market capitalizations. It employs fundamental and quantitative analysis, with focus on top-down and bottom-up approach to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Healthcare Index. It emp[loys in-house research to manage its portfolio. Healthcare Special Opportunities Fund was formed on June 26, 2015 and is domiciled in the United States.

www.ldic.ca/healthcare-special-opportunities-fund

--

Full Time Employees

--

Fiscal Year Ends

Recent News: MDS-UN.TO

View More

Performance Overview: MDS-UN.TO

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

MDS-UN.TO
0.00%
S&P/TSX Composite index
1.84%

1-Year Return

MDS-UN.TO
11.95%
S&P/TSX Composite index
20.13%

3-Year Return

MDS-UN.TO
7.16%
S&P/TSX Composite index
18.14%

5-Year Return

MDS-UN.TO
17.25%
S&P/TSX Composite index
46.63%

Compare To: MDS-UN.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDS-UN.TO

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    20.40M

  • Enterprise Value

    --

  • Trailing P/E

    6.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.25

  • Price/Book (mrq)

    0.95

  • Enterprise Value/Revenue

    6.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    1.89

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: MDS-UN.TO

View More

People Also Watch